Edition:
United States

Insider Trading: Merck & Co Inc (MRK.N)

MRK.N on New York Stock Exchange

65.91USD
20 Sep 2017
Change (% chg)

$-0.04 (-0.06%)
Prev Close
$65.95
Open
$66.00
Day's High
$66.31
Day's Low
$65.91
Volume
148,489
Avg. Vol
2,824,696
52-wk High
$66.80
52-wk Low
$58.29

All Insider Trades
Trading Date Name Title Type Shares Traded Price
11 May 2017

Kidder (C Robert)

Director Buy 5,000 $35.19
11 May 2017

Kidder (C Robert)

Director Sell 5,000 $63.54
8 May 2017

Ambrose Adele D

Officer Sell 960 $64.01
8 May 2017

Davis (Robert M)

Chief Financial Officer Buy 85,881 $0.00
8 May 2017

Davis (Robert M)

Chief Financial Officer Sell 44,530 $64.01
8 May 2017

Ambrose Adele D

Officer Buy 2,576 $0.00
8 May 2017

Karachun (Rita A)

Officer Sell 960 $64.01
8 May 2017

Karachun (Rita A)

Officer Buy 2,576 $0.00
1 May 2017

Chattopadhyay (Sanat)

Officer Sell 974 $62.38
1 May 2017

Chattopadhyay (Sanat)

Officer Buy 3,092 $0.00
1 May 2017

Gerberding (Julie L)

Officer Sell 1,078 $62.38
1 May 2017

Gerberding (Julie L)

Officer Buy 3,092 $0.00
2 Apr 2017

Schechter (Adam H)

Officer Sell 53,850 $63.48
26 Feb 2017

Ambrose Adele D

Officer Buy 2,795 $65.85
26 Feb 2017

Chattopadhyay (Sanat)

Officer Buy 3,758 $65.85
26 Feb 2017

Frazier (Kenneth C)

Chief Executive Officer Buy 101,552 $65.85
26 Feb 2017

Davis (Robert M)

Chief Financial Officer Buy 31,913 $65.85
26 Feb 2017

Schechter (Adam H)

Officer Buy 39,970 $65.85
26 Feb 2017

Perlmutter (Roger M)

Officer Buy 32,670 $65.85
26 Feb 2017

Holston Michael J

General Counsel Buy 12,159 $65.85
26 Feb 2017

Deluca Richard R Jr

Officer Buy 11,771 $65.85
26 Feb 2017

Karachun (Rita A)

Officer Buy 2,797 $65.85
26 Feb 2017

Gerberding (Julie L)

Officer Buy 3,707 $65.85
26 Feb 2017

Graddick-Weir (Mirian M)

Officer Buy 16,995 $65.85
13 Feb 2017

Karachun (Rita A)

Officer Sell 2,954 $64.73

Institutional Holders

% Shares Owned: 75.53%
# of Holders: 2,481
Total Shares Held: 2,059,901,773
3 Mo. Net Change: -15,558,091
# New Positions: 96
# Closed Positions: 98
# Increased Positions: 968
# Reduced Positions: 1,005
# Net Buyers: -37

Officers & Directors

Name Age Since Current Position

Kenneth Frazier

62 2011 Chairman of the Board, President, Chief Executive Officer

Robert Davis

50 2014 Chief Financial Officer, Executive Vice President

Michael Holston

54 2015 Executive Vice President, General Counsel

Mirian Graddick-Weir

62 2009 Executive Vice President - Human Resources

Sanat Chattopadhyay

57 2016 Executive Vice President and President - Merck Manufacturing Division

Richard DeLuca

54 2011 Executive Vice President, President - Merck Animal Health

Julie Gerberding

61 2016 Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health

Roger Perlmutter

65 2013 Executive Vice President, President - Merck Research Laboratories

Adam Schechter

52 2010 Executive Vice President, President - Global Human Health

Rita Karachun

53 2014 Senior Vice President Finance - Global Controller

Adele Ambrose

60 2009 Senior Vice President, Chief Communications Officer

Leslie Brun

64 2016 Lead Independent Director

Thomas Cech

70 2009 Independent Director

Pamela Craig

60 2015 Independent Director

Thomas Glocer

57 2007 Independent Director

Rochelle Lazarus

69 2004 Independent Director

Carlos Represas

72 2009 Independent Director

Paul Rothman

59 2015 Independent Director

Patricia Russo

64 1995 Independent Director

Craig Thompson

64 2008 Independent Director

Wendell Weeks

57 2004 Independent Director

Peter Wendell

66 2003 Independent Director